Why Biotech Giant Amgen's Q1 Results Indicate the Need for an M&A

Amgen has demonstrated a pretty good track record of beating Wall Street earnings estimates. The big biotech kept the streak going when it announced first-quarter results on Wednesday after the market closed.

However, those results also highlighted the importance of Amgen making an acquisition to fuel future growth. Here's how Amgen performed in the first quarter -- and why the company needs to be looking at potential deals.

Back to news